Trial Profile
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2023
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 05 Apr 2023 Status changed from active, no longer recruiting to completed.
- 19 Oct 2022 Planned End Date changed from 26 Feb 2022 to 31 Jan 2023.
- 19 Oct 2022 Status changed to active, no longer recruiting.